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Telomerase activity and telomere lengths: Alterations in renal constitutional situation) of 60 patients with RCC were
cell carcinomas. Detection of telomerase activity in renal cell obtained after nephrectomy and were frozen in liquid
carcinomas may be a key to understanding the loss of growth
nitrogen. If available, we analyzed material from thecontrol in tumor cells. This enzyme forms the end of most
tumor center and from different areas of the tumor pe-chromosomal DNAs (that is, telomeres) found in renal tumors.
When activated, the telomeres shorten with every cell cycle riphery. All of the samples were examined histopatho-
and then there is a compensatory lengthening of the cells, logically.
which then proliferate and eventually become immortal and
metastasize. This complex multigenetic process may prove to
Telomerase assay (telomeric repeatbe a useful marker of tumor progression and patient outcome.
amplification protocol)
The presence of telomerase in cells was detected by
Telomerase is an often present enzyme in malignant adding an oligonucleotide to the cell lysate and determin-
tumors and is absent from most human somatic tissues. ing the telomerase-mediated elongation of this template
This enzyme forms the ends of chromosomal DNAs (that with a PCR assay.
is, telomeres) by adding hexameric (TTAGGG)n nucle-
Approximately 50 mg of the frozen tissues samplesotide repeats. In cells lacking active telomerase, the telo-
were homogenized, and the S100 protein extracts weremeres shorten with every cell cycle, resulting in cellular
isolated as described by Kim et al [1]. The concentrationsenescence. Cells expressing telomerase compensate for
of protein was measured using the Bio-Rad protein assaythe loss of telomeric DNA. In this way, tumors gain
kit. An aliquot of extract containing 3.0 and 1.5 mg ofthe ability of indefinite cell proliferation and become
protein was used for each assay. The protein was mixedimmortal. The absence of telomerase in most somatic
with 75 mm Tris-HCl (pH 8.3), 1.5 mm magnesium chlo-cells and its presence in most malignant tumors render
ride, 20 mm ammonium sulfate, 0.01% Tween 20, 50 mmthe enzyme a prevalent diagnostic marker.
dNTPs, 0.05 mg TS oligonucleotide (59-AATCCGTC-Renal cell carcinomas (RCCs) are heterogeneous con-
cerning clinical behavior and prognosis. Therefore, the GAGCAGAGTT-39 labeled with the infrared dye IRD
measurement of telomerase activity might provide addi- 41), and 0.5 mg T4 gene 32 protein (Pharmacia, Uppsala,
tional information that may be useful as a marker for Sweden) in a total volume of 25 ml. The reaction mixture
tumor progression and patients’ outcome. was incubated for 10 minutes at 238C for the telomerase-
Based on a polymerase chain reaction (PCR) assay, we mediated extension of the TS primer and was then
detected telomerase activity in 55 out of 60 primary RCCs. heated at 908C for 90 seconds. After adding 0.05 mg
Additionally, we analyzed tumor DNA in comparison to CX primer (59-CCCTTACCCTTACCCTTACCCTTA-
the normal tissue for changes in the length of telomeres. 39) and 1 unit of Taq DNA polymerase (Eurogentec,
Seraing, Belgium), the probes were subjected to 31 PCR
METHODS cycles of 948C for 30 seconds, 508C for 30 seconds, and
728C for 45 seconds. Three microliters of each PCR prod-Samples
uct was separated by electrophoresis on a 6% denaturat-Tumor tissue and the adjacent normal renal cortex
ing polyacrylamide gel using a LI-COR DNA sequencertissue free of tumor cells (0.1 to 0.5 g; representing the
(MWG-Biotech, Ebersberg, Germany). The laser detec-
tion system of the LI-COR makes the extended andKey words: tumors, cancer, chromosomal aberrations, growth control,
genomic instability. amplificated PCR products visible as an increasing DNA
ladder. 1999 by the International Society of Nephrology
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Detection of telomere lengths point of critical telomere shortening, telomerase might
be reactivated to stabilize the telomeric repeats, and cellsTelomere lengths were detected as the mean telomeric
become immortal.repeat fragment length (TRF) by analyzing Southern
The detection of telomerase activity in the majorityblots with the oligonucleotide probe (TTAGGG)3.
(92%) of RCCs implies that telomerase activation mayConstitutional and tumor DNA were prepared with
be required as a critical step in the multigenetic processstandard methods following Lagoda et al [2]. After diges-
of tumorigenesis of RCCs. The expression of telomerasetion of equal amounts (10 mg) of DNA with the restric-
was independent of tumor size, stage of tumor (grading),tion enzyme Hinf 1, the samples were electrophoresed,
and histological RCC subtype. This indicates that te-and separated fragments were denaturated in alkali and
lomerase activation is not necessarily a late event in thewere transferred to nylon membranes. Subsequently, hy-
progression of all kind of RCC types.bridization with the digoxigenin-labeled oligonucleotide
Once cancer cells acquire telomerase activity, theirprobe (TTAGGG)3 was performed. Hybridization sig-
TRF sizes could be stabilized at any length. The balancenals were obtained by chemiluminescence using 25 mm
between the loss of TRF at each cycle of DNA replica-CSPD (Tropix/Serva, Heidelberg, Germany).
tion and the telomere elongation caused by telomeraseFor the evaluation of the length of telomeres, x-ray
activity leads to a variability of TRF lengths in tumorfilms were scanned using an RFLPscan one-dimensional
cells. This supposition is also reflected in our data. Weelectrophoresis analysis software (Scanalytics, Billerica,
detected (a) cases with shortened telomeres and lack ofMA, USA). The TRF was estimated by measuring and
telomerase in the tumor tissue, (b) cases with no alter-integrating the optical density under the peak position
ation in the telomere length between constitutional andof the hybridization signal and by determining the mean.
tumor cells but telomerase activity in the tumor, and (c)To avoid artifacts that were due to loading differences
cases in which telomeres were shortened and telomeraseand to check for complete digestion of DNA, all blots
was activated in the tumor. Interestingly, in some cases,were hybridized with the oligonucleotide probe (CAC)5. telomere shortening occurred in only parts of the tumor,
suggesting an intratumoral heterogeneity of RCCs. Two
cases with elongated telomeres in the tumor in compari-RESULTS
son to the normal tissue could demonstrate the attain-Telomerase activity was detected in 55 out of 60 RCC
ment of immortality for these tumor cells.(92%). All corresponding normal kidney tissues that
All metastasizing tumors displayed telomerase activ-were used as control were negative for telomerase. The
ity. Telomerase-negative primary tumors (5 cases) didfive patients with telomerase-deficient primary tumors
not metastasize. These results indicate that telomerase-had no secondary tumors or metastases at the time of
positive RCCs have perhaps more malignant potentialtumor resection. We found no correlation between te-
than do those without telomerase activity. The correla-lomerase activity and histopathological grading, tumor
tion of the survival rate of the patients with metastaticstaging, or tumor subtype. The karyotypes of telomerase-
potential and telomerase activity might prove to be aactive cells did not demonstrate specific chromosomal
useful prognostic marker for tumor progression and pa-aberrations.
tients’ outcome.
Twenty-five percent of the RCCs in our study had no
Reprint requests to Dr. R. Dahse, Institute of Human Genetics andalteration in telomere length between constitutional and
Anthropology, University of Jena, Kollegiengasse 10, D-07740 Jena,tumor tissue. In 72%, telomeres in tumor cells were
Germany.
reduced. Two cases with elongated telomeres in the tu-
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